Syneos Health, Inc. (SYNH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Visitors trend2W10W9M

33.94

-0.10

(-0.29%)

At close: 01:00PM EST

34.26

+0.32

(+0.94%)

After hours:

03:03PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

MACD

View all chart patterns

Performance Outlook

Previous Close	34.04
Open	33.96
Bid	33.86 x 900
Ask	40.00 x 1200
Day's Range	32.62 - 34.45
52 Week Range	22.89 - 104.17
Volume	382,784
Avg. Volume	1,179,023

Market Cap	3.493B
Beta (5Y Monthly)	1.75
PE Ratio (TTM)	12.08
EPS (TTM)	2.81
Earnings Date	Feb 15, 2023 - Feb 20, 2023
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	38.45

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Near Fair Value

-5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SYNH

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Syneos Health, Inc.
SYNH: Raising target price to $36.00SYNEOS HEALTH INC has an Investment Rating of HOLD; a target price of $36.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
3 days agoArgus Research

All

Simply Wall St.
Syneos Health, Inc.'s (NASDAQ:SYNH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 48% over the past three months, it is easy to disregard Syneos Health (NASDAQ:SYNH). However, stock...
- Are Robust Financials Driving The Recent Rally In Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock?
  Simply Wall St.
- A Note On Bristol-Myers Squibb Company's (NYSE:BMY) ROE and Debt To Equity
  Simply Wall St.
Insider Monkey
Is Investing in Syneos Health (SYNH) Risky?
Carillon Tower Advisers, an investment management company, released its “Carillon Chartwell Mid Cap Value Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. The market witnessed extreme volatility in the quarter, and the equity market segment returns ranged from -2% to -5%. The Russell Mid Cap Value index declined nearly […]
GlobeNewswire
Syneos Health to Participate in Fireside Chat at the 2022 Evercore ISI HealthCONx Conference
MORRISVILLE, N.C., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe is scheduled to participate in a fireside chat at the 2022 Evercore ISI HealthCONx Conference on December 1, 2022, at 7:00 a.m. ET. The Company will not be hosting investor meetings. A live webcast of the event, along with a link to the archived replay will be available on the Company’s I